Alpha 2.0
Login Register
» Authors » Neeta Singla

Neeta Singla

Explore the profile of Neeta Singla including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 287
Followers 0
Related Specialties
Infectious Diseases
Pulmonary Medicine
General Medicine
Top 10 Co-Authors
Rupak Singla
Rohit Sarin
Amitesh Gupta
Vikram Vohra
Ashwani Khanna
Pruthu Thekkur
V P Myneedu
U K Khalid
Vithal Prasad Myneedu
V K Arora
Published In
Indian J Tuberc
Trop Med Infect Dis
Indian J Chest Dis Allied Sci
PLoS One
Monaldi Arch Chest Dis
Affiliations
Soon will be listed here.
Recent Articles
1.
Bedaquiline Resistance and Treatment Outcomes Among Patients With Tuberculosis Previously Exposed to Bedaquiline in India: A Multicentric Retrospective Cohort Study
Singla R, Khan S, Silsarma A, Chavan V, Mahajan R, Mansoor H, et al.
Clin Infect Dis . 2025 Mar; PMID: 40079698
Background: Bedaquiline (BDQ) resistance presents a critical challenge in the fight against tuberculosis (TB), particularly multidrug-resistant (MDR) strains. The emergence of resistance to BDQ, a key drug in treating MDR-TB,...
2.
Clinical profile, risk factors, disease severity, and outcome for COVID-19 disease in patients with tuberculosis on treatment under the National Tuberculosis Elimination Program: a cohort of 1400 patients
Singla N, Gupta A, Khalid U, Dewan R, Singla R
Monaldi Arch Chest Dis . 2024 Nov; PMID: 39526507
COVID-19 affected millions of people worldwide, and tuberculosis (TB) continues to affect millions of people each year. The combined pandemic of COVID-19 and TB had a catastrophic effect on healthcare...
3.
Effectiveness and Safety of Varying Doses of Linezolid With Bedaquiline and Pretomanid in Treatment of Drug-Resistant Pulmonary Tuberculosis: Open-Label, Randomized Clinical Trial
Padmapriyadarsini C, Oswal V, Jain C, Mariappan M, Singla N, Kumar S, et al.
Clin Infect Dis . 2024 Aug; 79(6):1375-1385. PMID: 39194339
Background: Treatment of drug-resistant tuberculosis with bedaquiline-pretomanid-linezolid regimen has demonstrated good treatment efficacy. Given linezolid's toxicity profile, prudence suggests reconsidering its dose and duration. We determined the effectiveness and safety...
4.
Situation Analysis of Early Implementation of Programmatic Management of Tuberculosis Preventive Treatment among Household Contacts of Pulmonary TB Patients in Delhi, India
Alvi Y, Philip S, Anand T, Chinnakali P, Islam F, Singla N, et al.
Trop Med Infect Dis . 2024 Jan; 9(1). PMID: 38251221
Tuberculosis Preventive Treatment (TPT) is a powerful tool for preventing the TB infection from developing into active TB disease, and has recently been expanded to all household contacts of TB...
5.
Test and Treat Model for Tuberculosis Preventive Treatment among Household Contacts of Pulmonary Tuberculosis Patients in Selected Districts of Maharashtra: A Mixed-Methods Study on Care Cascade, Timeliness, and Early Implementation Challenges
Mahajan P, Soundappan K, Singla N, Mehta K, Nuken A, Thekkur P, et al.
Trop Med Infect Dis . 2024 Jan; 9(1). PMID: 38251204
Tuberculosis preventive treatment (TPT) is an important intervention in preventing infection and reducing TB incidence among household contacts (HHCs). A mixed-methods study was conducted to assess the "Test and Treat"...
6.
Outcomes and Challenges in the Programmatic Implementation of Tuberculosis Preventive Therapy among Household Contacts of Pulmonary TB Patients: A Mixed-Methods Study from a Rural District of Karnataka, India
Samudyatha U, Soundappan K, Ramaswamy G, Mehta K, Kumar C, Jagadeesh M, et al.
Trop Med Infect Dis . 2023 Dec; 8(12). PMID: 38133444
The National TB Elimination Programme (NTEP) of India is implementing tuberculosis preventive treatment (TPT) for all household contacts (HHCs) of pulmonary tuberculosis patients (index patients) aged <5 years and those...
7.
Chronic pulmonary aspergillosis in a tertiary tuberculosis institute: A common entity missed commonly
Singhal R, Gupta A, Singla N, Singla R, Jha R, Raina S, et al.
Indian J Tuberc . 2023 Aug; 70(3):276-285. PMID: 37562901
The disease chronic pulmonary aspergillosis (CPA), which has 3 million cases globally, has a substantial impact on global health. The morbidity and mortality it cause are also rather severe. Patients...
8.
Long-Term Intake of Linezolid Elevates Drug Exposure and Reduces Drug Clearance and Elimination in Adults With Drug-Resistant Pulmonary Tuberculosis
Jeyakumar S, Bhui N, Singla N, Vilvamani S, Mariappan M, Padmapriyadarsini C, et al.
Ther Drug Monit . 2023 Jun; 45(6):754-759. PMID: 37296501
Purpose: Pharmacokinetic (PK) studies are critical for dose optimization, and there is a paucity of linezolid (LZD) PK data for prolonged use in drug-resistant tuberculosis (DR-TB). Therefore, the authors evaluated...
9.
Preparedness for establishing COVID-19 services during acute emergency of COVID-19 pandemic: Experience of a tertiary care TB and respiratory diseases hospital
Singla N, Saini J, Purwar P, Yadav P, Gupta A, Dewan R
Indian J Tuberc . 2022 Dec; 69(4):608-612. PMID: 36460397
Background: The ongoing coronavirus disease 2019 (COVID-19) calls for setting up of well-equipped and dedicated health facilities to manage sick patients while protecting healthcare workers and the environment. An ideal...
10.
Factors affecting the treatment outcome of injection based shorter MDR-TB regimen at a referral centre in India
B K, Singla R, Singla N, V V, Singh K, Choudhury M, et al.
Monaldi Arch Chest Dis . 2022 Oct; 93(3). PMID: 36200688
Rifampicin-resistant/multidrug-resistant tuberculosis (RR/MDR-TB) is a significant burden on global tuberculosis (TB) prevention and eradication efforts. MDR-TB can be treated, but it is expensive, takes a long time (typically two years)...